A study suggests updating pre-eclampsia screening after identifying a bias in IVF pregnancies conceived in artificial cycles

Un estudio sugiere actualizar el cribado de preeclampsia tras identificar un sesgo en embarazos por FIV en ciclo artificial

A study suggests updating pre-eclampsia screening after identifying a bias in IVF pregnancies conceived in artificial cycles

Valeria Donno, Pilar Prats, Marta Plancha, Ignacio Rodriguez, Kypros Nicolaides, Nikolaos P Polyzos.
Am J Obstet Gynecol. 2026 Feb 21:S0002-9378(26)00103-1.
DOI: 10.1016/j.ajog.2026.02.031

A large‑scale study conducted by Dexeus Mujer and recently published in the American Journal of Obstetrics & Gynecology, has shown that pregnancies achieved through frozen embryo transfer in an artificial cycle exhibit significantly lower uterine vascular resistance during the second and third trimester, yet display an incidence of pre‑eclampsia up to four times higher than other modes of conception.

The study analysed 27,495 singleton pregnancies monitored between 2010 and 2024, including natural conceptions, ovulation induction, insemination, fresh embryo transfer IVF and frozen embryo transfer IVF. The results reveal that artificial‑cycle frozen embryo transfers show the lowest uterine pulsatility index values in the second and third trimester, compared with natural pregnancies or natural‑cycle frozen embryo transfers.

Despite this improved uterine perfusion, these pregnancies presented a 5.2% incidence of pre‑eclampsia, markedly higher than that observed in natural pregnancies (1.4%), natural‑cycle frozen embryo transfers (1.1%) or fresh IVF (2.2%). The authors note that this discrepancy highlights a systematic bias in current screening algorithms, which interpret low resistance values as an indicator of low risk.

The Dr Valeria Donno, lead author, emphasises that the findings reinforce the urgent need to revise second‑ and third‑trimester screening algorithms to ensure early identification and appropriate clinical management of high‑risk pregnancies.

The study included the participation of Prof. Kypros Nicolaides, a global pioneer and leading figure in the development of fetal medicine.

How can we help you?

We inform you that the personal data that you provide by filling in this form will be treated by Dexeus Mujer Foundation as responsible for this website. The purpose of collecting and processing this data is to contact you regarding your request and in the event that you expressly authorize us to send you information on activities, promotions and / or services and our periodic newsletter. The legitimation is carried out through the consent of the interested party. You can exercise your rights of access, rectification, limitation and delete the data before the data protection officer at dpd@dexeus.com as well as the right to file a claim with a control authority. You can consult the additional and detailed information on Data Protection in our privacy policy.

How can we help you?

We inform you that the personal data that you provide by filling in this form will be treated by Dexeus Mujer Foundation as responsible for this website. The purpose of collecting and processing this data is to contact you regarding your request and in the event that you expressly authorize us to send you information on activities, promotions and / or services and our periodic newsletter. The legitimation is carried out through the consent of the interested party. You can exercise your rights of access, rectification, limitation and delete the data before the data protection officer at dpd@dexeus.com as well as the right to file a claim with a control authority. You can consult the additional and detailed information on Data Protection in our privacy policy.